Liraglutide 3.0 emg efficacy and safety by baseline BMI in the SCALE Diabetes trial: post-hoc analysis

被引：0
|
作者：
Hemmingsson, J. Udden [1 ]
Rosenstock, J. [2 ]
Davies, M. [3 ]
Bays, H. [4 ]
Cancino, A. -P. [5 ]
Skjoth, T. V. [5 ]
Aroda, V. [6 ]
机构：
[1] Capio St Gorans Hosp, Stockholm, Sweden
[2] Diabet & Endocrine Ctr, Dallas, TX USA
[3] Univ Leicester, Leicester LE1 7RH, Leics, England
[4] L MARC Res Ctr, Louisville, KY USA
[5] Novo Nordisk, Soborg, Denmark
[6] MedStar Hlth Res Inst, Hyattsville, MD USA
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
646
引用
收藏
页码：S311 / S311
页数：1
相关论文
共 50 条
  • [31] A POST-HOC ANALYSIS OF THE SAFETY AND EFFICACY OF RIX-FP IN ADOLESCENT PATIENTS WITH HAEMOPHILIA B
    Roman, Maria Alvarez
    Drelich, Douglass
    Seifert, Wilfried
    Castaman, Giancarlo
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S170 - S171
  • [32] Lixisenatide and renal outcomes in patients with type 2 diabetes: a post-hoc analysis of the ELIXA trial
    Muskiet, M. H. A.
    Heerspink, H. J. L.
    Tonneijck, L.
    Huang, Y.
    Liu, M.
    Saremi, A.
    van Raalte, D. H.
    DIABETOLOGIA, 2018, 61 : S40 - S40
  • [33] Efficacy and safety of semaglutide in elderly subjects with type 2 diabetes: a post hoc analysis of the SUSTAIN 7 trial
    Aroda, V. R.
    Sugimoto, D.
    Trachtenbarg, D.
    Warren, M.
    Navarria, A.
    Nayak, G.
    Nielsen, M. Abildlund
    Woo, V.
    DIABETOLOGIA, 2018, 61 : S367 - S367
  • [34] Febuxostat and renal outcomes: post-hoc analysis of a randomized trial
    Kohagura, Kentaro
    Kojima, Sunao
    Uchiyama, Kazuaki
    Yokota, Naoto
    Tokutake, Eiichi
    Wakasa, Yutaka
    Hiramitsu, Shinya
    Waki, Masako
    Jinnouchi, Hideaki
    Kakuda, Hirokazu
    Hayashi, Takahiro
    Kawai, Naoki
    Sugawara, Masahiro
    Mori, Hisao
    Tsujita, Kenichi
    Matsui, Kunihiko
    Hisatome, Ichiro
    Ohya, Yusuke
    Kimura, Kazuo
    Saito, Yoshihiko
    Ogawa, Hisao
    HYPERTENSION RESEARCH, 2023, 46 (06) : 1417 - 1422
  • [35] Febuxostat and renal outcomes: post-hoc analysis of a randomized trial
    Kentaro Kohagura
    Sunao Kojima
    Kazuaki Uchiyama
    Naoto Yokota
    Eiichi Tokutake
    Yutaka Wakasa
    Shinya Hiramitsu
    Masako Waki
    Hideaki Jinnouchi
    Hirokazu Kakuda
    Takahiro Hayashi
    Naoki Kawai
    Masahiro Sugawara
    Hisao Mori
    Kenichi Tsujita
    Kunihiko Matsui
    Ichiro Hisatome
    Yusuke Ohya
    Kazuo Kimura
    Yoshihiko Saito
    Hisao Ogawa
    Hypertension Research, 2023, 46 : 1417 - 1422
  • [36] Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis
    Miao Yu
    Guo Yue Yuan
    Bin Zhang
    Hai Ya Wu
    Xiao Feng Lv
    Diabetes Therapy, 2020, 11 : 1147 - 1159
  • [37] Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial
    Riddle, Matthew C.
    Gerstein, Hertzel C.
    Xavier, Denis
    Cushman, William C.
    Leiter, Lawrence A.
    Raubenheimer, Peter J.
    Atisso, Charles M.
    Raha, Sohini
    Varnado, Oralee J.
    Konig, Manige
    Lakshmanan, Mark
    Franek, Edward
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (05): : 1345 - 1351
  • [38] Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis
    Yu, Miao
    Yuan, Guo Yue
    Zhang, Bin
    Wu, Hai Ya
    Lv, Xiao Feng
    DIABETES THERAPY, 2020, 11 (05) : 1147 - 1159
  • [39] The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial
    Chen, Lei
    Phillips, Glenn
    Johnston, Joseph
    Kinon, Bruce J.
    Ascher-Svanum, Haya
    Kollack-Walker, Sara
    Succop, Paul
    Naber, Dieter
    BMC PSYCHIATRY, 2011, 11
  • [40] Efficacy of liraglutide added to sodium-glucose cotransporter-2 inhibitors in type 2 diabetes, stratified by baseline characteristics: Post-hoc analysis of LIRA-ADD2SGLT2i
    Blonde, Lawrence
    Fainberg, Udi
    Kaltoft, Margit S.
    Mosenzon, Ofri
    Ramesh, Chethana
    Rea, Rosangela
    DIABETES OBESITY & METABOLISM, 2021, 23 (10): : 2234 - 2241
12345